Biblio
“Ligand-Specific Transcriptional Mechanisms Underlie Aryl Hydrocarbon Receptor-Mediated Developmental Toxicity of Oxygenated PAHs”, Toxicological Sciences, vol. 147, no. 2, pp. 397 - 411, 2015.
, “Low-Dose Mixture Hypothesis of Carcinogenesis Workshop: Scientific Underpinnings and Research Recommendations.”, Environ Health Perspect, 2017.
, “LSD1 activates a lethal prostate cancer gene network independently of its demethylase function.”, Proc Natl Acad Sci U S A, 2018.
, “Mechanisms of environmental chemicals that enable the cancer hallmark of evasion of growth suppression”, Carcinogenesis, vol. 36, pp. S2–S18, 2015.
, “Mechanistic investigations into the developmental toxicity of nitrated and heterocyclic PAHs.”, Toxicol Sci, 2017.
, “Metabolic reprogramming and dysregulated metabolism: cause, consequence and/or enabler of environmental carcinogenesis?”, Carcinogenesis, vol. 36, pp. S203–S231, 2015.
, “Modeling of the aryl hydrocarbon receptor (AhR) ligand binding domain and its utility in virtual ligand screening to predict new AhR ligands.”, J Med Chem, vol. 52, no. 18, pp. 5635-41, 2009.
, “Modeling of the aryl hydrocarbon receptor (AhR) ligand binding domain and its utility in virtual ligand screening to predict new AhR ligands”, Journal of medicinal chemistry, vol. 52, pp. 5635–5641, 2009.
, “Modeling of the Aryl Hydrocarbon Receptor (AhR) Ligand Binding Domain and Its Utility in Virtual Ligand Screening to Predict New AhR Ligands”, Journal of Medicinal Chemistry, vol. 52, no. 18, pp. 5635 - 5641, 2009.
, “Molecular basis of agonicity and antagonicity in the androgen receptor studied by molecular dynamics simulations”, Journal of Molecular Graphics and Modelling, vol. 27, no. 4, pp. 452 - 458, 2008.
, “Mono-substituted isopropylated triaryl phosphate, a major component of Firemaster 550, is an AHR agonist that exhibits AHR-independent cardiotoxicity in zebrafish”, Aquatic Toxicology, vol. 154, pp. 71–79, 2014.
, “Mono-substituted isopropylated triaryl phosphate, a major component of Firemaster 550, is an AHR agonist that exhibits AHR-independent cardiotoxicity in zebrafish”, Aquatic Toxicology, vol. 154, pp. 71 - 79, 2014.
, “Mono-substituted isopropylated triaryl phosphate, a major component of Firemaster 550, is an AHR agonist that exhibits AHR-independent cardiotoxicity in zebrafish.”, Aquat Toxicol, vol. 154, pp. 71-9, 2014.
, “Polyphenolics from mango (Mangifera indica L.) suppress breast cancer ductal carcinoma in situ proliferation through activation of AMPK pathway and suppression of mTOR in athymic nude mice.”, J Nutr Biochem, vol. 41, pp. 12-19, 2016.
, “The potential for chemical mixtures from the environment to enable the cancer hallmark of sustained proliferative signalling”, Carcinogenesis, vol. 36, pp. S38–S60, 2015.
, “Self-assembling cannabinomimetics: supramolecular structures of N-alkyl amides”, Journal of natural products, vol. 70, pp. 1010–1015, 2007.
, “Site-specific proteomic analysis of lipoxidation adducts in cardiac mitochondria reveals chemical diversity of 2-alkenal adduction”, Journal of proteomics, vol. 74, pp. 2417–2429, 2011.
, “Solution Structure, Dimerization, and Dynamics of a Lipophilic $\alpha$/310-Helical, C$\alpha$-Methylated Peptide. Implications for Folding of Membrane Proteins”, Journal of the American Chemical Society, vol. 123, pp. 6678–6686, 2001.
, “A Structural Switch between Agonist and Antagonist Bound Conformations for a Ligand-Optimized Model of the Human Aryl Hydrocarbon Receptor Ligand Binding Domain”, Biology, vol. 399, no. 4, pp. 645 - 669, 2014.
, “A structural switch between agonist and antagonist bound conformations for a ligand-optimized model of the human aryl hydrocarbon receptor ligand binding domain”, Biology, vol. 3, pp. 645–669, 2014.
, “A Structural Switch between Agonist and Antagonist Bound Conformations for a Ligand-Optimized Model of the Human Aryl Hydrocarbon Receptor Ligand Binding Domain.”, Biology (Basel), vol. 3, no. 4, pp. 645-69, 2014.
, “Structure-activity relationships of the main bioactive constituents of Euodia ruticarpa on aryl hydrocarbon receptor activation and bile acid homeostasis”, Drug Metabolism and Disposition, p. dmd.117.080176, 2018.
, “Suppression of cytokine-mediated complement factor gene expression through selective activation of the Ah receptor with 3′, 4′-dimethoxy-$\alpha$-naphthoflavone”, Molecular pharmacology, vol. 79, pp. 508–519, 2011.
, “Synthesis and binding studies of epibatidine analogues as ligands for the nicotinic acetylcholine receptors”, European journal of medicinal chemistry, vol. 41, pp. 640–650, 2006.
, “Synthesis and biological evaluation of benzo [4, 5] imidazo [1, 2-c] pyrimidine and benzo [4, 5] imidazo [1, 2-a] pyrazine derivatives as anaplastic lymphoma kinase inhibitors”, Bioorganic & medicinal chemistry, vol. 22, pp. 1303–1312, 2014.
,